FDA Inspection
Nephron Sc IncNephron Sc Inc – FDA Inspection, Jan 20, 2017
Record Details
This FDA Inspection record concerns Nephron Sc Inc, with an inspection on January 20, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · fff9017e-05a7-4425-8b76-2e51459e0c0a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1006544
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.192Extent of discrepancy, failure investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nephron Sc Inc
12| Date | Classification | Office | Project area |
|---|---|---|---|
| August 22, 2025 | Not classified | Atlanta District Office | Drug Quality Assurance |
| September 25, 2024 | Not classified | Atlanta District Office | Drug Quality Assurance |
| February 9, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 10, 2023 | OAI | Drug Quality Assurance | |
| April 20, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nephron Sc Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.